ESTUDIO DE EXTENSIÓN DEL ESTUDIO AC-055-305 A LARGO PLAZO, ABIERTO, DE BRAZO ÚNICO PARA VALORAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE MACITENTAN EN SUJETOS CON EL SÍNDROME DE EISENMENGER.

Datos básicos

Código:
AC-055-308
Protocolo:
AC-055-308
EUDRACT:
2012-004411-31
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2014
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ACTELION PHARMACEUTICALS
ACTELION PHARMACEUTICALS LTD

Resultados del Ensayo Clínico


[[en]]Peripheral access ultrafiltration in adults with complex congenital heart disease and refractory congestion.

Guerrero Cervera B; (...); Almenar Bonet L

Article. 10.1016/j.rec.2024.08.015. 2024

  • Open Access.

[Farewell open letter to SEFH members].

Poveda Andrés JL

Editorial Material. 10.7399/fh.2015.39.6.10128. 2015

  • Open Access.

[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

  • Open Access.

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024

  • Open Access.

[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024

  • Open Access.

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

  • Open Access.

2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11611. 2021

  • Open Access.

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022

  • Open Access.

A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya, Neboa; (...); Verde, Luis

Article. 10.1017/S0266462322000459. 2022

  • Open Access.

A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F; (...); Martínez-Olmos J

Article. 10.1007/s41669-020-00201-2. 2020

  • Open Access.

A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.

Casado, MA; (...); Grp MULTIDEX-EMD

Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018

  • Open Access.

A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020

  • Open Access.

A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Article. 10.1038/tpj.2015.80. 2016


Activation of (1A)-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing

Arce, C; (...); Dolores Ivorra, Maria

Article. 10.1111/bph.13800. 2017

  • Open Access.

Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020


Administration of Subcutaneous Furosemide in Elastomeric Pump vs. Oral Solution for the Treatment of Diuretic Refractory Congestion.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.1007/s40292-021-00476-4. 2021


Adult congenital heart disease in Spain: health care structure and activity, and clinical characteristics.

Oliver Ruiz JM; (...); Gallego P

Article. 10.1016/j.recesp.2019.09.007. 2020


Aflibercept in exudative age related macular degeneration refractory to ranibizumab.

Ruiz Ramos J; (...); Gallego-Pinazo R

Article. 10.1016/j.oftal.2015.07.018. 2015


Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1097/TP.0000000000004273. 2022

  • Open Access.

Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.09.003. 2021


Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.

Ruiz Ramos J; (...); Poveda Andrés JL

Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014

  • Open Access.

Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019

  • Open Access.

Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021


Analysis of Heart Transplant Survival According to Difference in Age Between Donor and Recipient.

Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.014. 2022


Analysis of heart transplantation survival according to difference in age between donor and recipient

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Analysis of hospital mortality and primary graft dysfunction in urgent heart transplantation according to the type and duration of circulatory/ventricular assistance

Vilella, RRL; (...); Bonet, LA

Meeting Abstract. 2017


Analysis of the Intrahospital and Long-Term Survival of Heart Transplant Patients With a Short-Term Mechanical Assistance Device.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.transproceed.2021.06.030. 2021


Anidulafungin-Induced Alopecia

Ruiz-Ramos J; (...); Poveda-Andrés JL

Article. 10.1177/1060028014524534. 2014


Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.

López-Vilella R; (...); Almenar Bonet L

Article. 10.1186/s12872-024-03728-y. 2024

  • Open Access.

Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018


Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018


Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-a antagonist therapy.

Genre F; (...); González-Gay MA

Article. 2013


Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023

  • Open Access.

Assessment of the quality of sample labelling for clinical research.

Pérez-Huertas P; (...); Poveda-Andrés JL

Article. 10.7399/fh.2016.40.2.9753. 2016

  • Open Access.

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

Sánchez-Lázaro I; (...); Aliño SF

Article. 10.2217/pgs.15.39. 2015


Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-a antagonist therapy.

Genre F; (...); González-Gay MA

Article. 2013


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

  • Open Access.

Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2018.12.027. 2019


beta 2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation

Rodriguez-Serrano, M; (...); D'Ocon, P

Article. 10.3389/fphar.2019.00093. 2019

  • Open Access.

beta(2)- and beta(1)-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases

Montó F; (...); D'Ocon P

Article. 10.1097/FJC.0000000000000299. 2015


Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

  • Open Access.

Biosimilares: viejas polemicas con nuevos argumentos.

Poveda-Andrés JL, Bosó-Ribelles V

Editorial Material. 10.7399/fh.2015.39.3.8978. 2015

  • Open Access.

BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017


Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017


CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023


CA125: a new biomarker in patients with Fontan circulation.

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Article. 10.1016/j.rec.2022.05.029. 2022


Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 2015


Can the number of Comorbidities predict readmissions for Heart Failure patients?

Ferre, MFM; (...); Almenar, L

Meeting Abstract. 2018


Carbohydrate antigen 125 and glutamic oxaloacetic transaminase as congestion markers in acute heart failure. Is there clinical association between them?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018


Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.3390/jpm12060913. 2022

  • Open Access.

Cardiac S1P/Ceramide imbalance in human heart failure: implication of gene dysregulation

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021


Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.

Alania-Torres, Edgardo; (...); Valle-Munoz, Alfonso

Case Reports. 10.3389/fcvm.2021.759119. 2021

  • Open Access.

CCSER2 and RAC3 serum expression levels detect cardiac allograft rejection

Rodriguez, J. M.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021


Circulating biomarkers for the detection of the pre-capillary component in patients with pulmonary hypertension due to left heart diseases

Ferrer, JLM; (...); Bonet, LA

Meeting Abstract. 2017


Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection.

Pérez-Carrillo L; (...); Roselló-Lletí E

Letter. 10.1186/s40364-024-00590-0. 2024

  • Open Access.

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021


Clinical evaluation of rituximab treatment for neuromyelitis optica

Fernández-Megía MJ; (...); Poveda-Andrés JL

Article. 10.1016/j.nrl.2014.09.001. 2015

  • Open Access.

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Lorente Fernández L; (...); Casanova-Estruch B

Article. 10.1016/j.nrl.2013.06.014. 2014

  • Open Access.

Clinical features and outcomes of adult patients with single ventricle physiology not undergoing Fontan repair

Gordon, B; (...); Rueda, J

Meeting Abstract. 2020


Clinical outcome of COVID-19 in patients with adult congenital heart disease.

Schwerzmann M; (...); EPOCH

Article. 10.1136/heartjnl-2020-318467. 2021

  • Open Access.

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

  • Open Access.

Clinical phenotypes according to diuretic combination in acute heart failure.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.hjc.2023.03.009. 2023

  • Open Access.

Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial

Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers

Article. 10.3389/fcvm.2024.1504427. 2025

  • Open Access.

Clinical profile of heart failure patients starting vericiguat in clinical practice

Esteban Fernandez, A. Alberto; (...); Diez Villanueva, P.

Meeting Abstract. 2024


Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.3389/fcvm.2024.1381514. 2024

  • Open Access.

Clinical Utility of the IMPACT Score for Mortality Prediction after Heart Transplantation: External Validation Study

Bautista, CDO; (...); Jimenez, JFD

Meeting Abstract. 10.1016/j.healun.2019.01.517. 2019


Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2024


Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients.

Pérez-Carrillo L; (...); Roselló-Lletí E

Article. 10.1097/TP.0000000000004622. 2023

  • Open Access.

Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients

Perez-Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022


COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021


Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.3390/biomedicines12092109. 2024

  • Open Access.

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020


Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.08.040. 2021


Comprehensive Long-Term Follow up of Adults with Arterial Switch Operation-European Collaboration for Prospective Outcome Research in Congenital Heart Disease (EPOCH-ASO)-Study Design and Protocols

Ruperti-Repilado, FJ; (...); Greutmann, M

Article. 10.32604/CHD.2020.012599. 2020

  • Open Access.

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

  • Open Access.

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023


Conventional and right-sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death

Alonso, P; (...); Martinez, L

Article. 10.1111/anec.12461. 2017

  • Open Access.

Correlates of musculoskeletal pain and kinesiophobia in older adults with heart failure: A structural equation model.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1016/j.gerinurse.2023.07.003. 2023


Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-a therapy.

Genre F; (...); González-Gay MÁ

Article. 2013


Correlation of various molecules involved in cellular traffic with the severity of heart failure in patients undergoing cardiac transplantation

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018


COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

  • Open Access.

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024


Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017


Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

  • Open Access.

COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018

  • Open Access.

Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice

Lorente-Fernandez, L; (...); Poveda-Andres, JL

Article. 10.1136/ejhpharm-2013-000426. 2015


COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020


Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

  • Open Access.

COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021


COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.transproceed.2021.07.054. 2021

  • Open Access.

COVID-19 infection in heart transplants in pre- and post-vaccination periods

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.005. 2022

  • Open Access.

Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.

López-Vilella R; (...); Almenar Bonet L

Article. 10.1080/00015385.2020.1871264. 2021

  • Open Access.

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1111/hae.13733. 2019


Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

  • Open Access.

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Article. 2022


CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN

Lopez-Vilella, R; (...); Almenar-Bonet, L

Meeting Abstract. 2021


Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

  • Open Access.

Changes in Adrenoceptor and GRK Expression in Patients With Chronic Pulmonary Regurgitation.

Rodríguez-Serrano M; (...); Martínez-Dolz L

Article. 10.1016/j.rec.2018.05.030. 2019


Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design

Minana, G; (...); Myocardial-IRON Investigators

Article. 10.1002/clc.22956. 2018

  • Open Access.

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study

Escribano-Subias, P; (...); Barbera, JA

Article. 10.1186/s12890-020-01197-5. 2020

  • Open Access.

Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.002. 2022


Changes over the years in the indication for heart-lung transplantation in Spain

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Characterisation of iPSCs from a patient with transposition of the great arteries

Ontoria-Oviedo, I; (...); Sepulveda, P

Meeting Abstract. 2017


Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019


De una asistencia biventricular mínimamente invasiva al implante de Heartware.

Pérez-Guillén M; (...); Torregrosa-Puerta S

Article. 10.24875/ACM.21000073. 2022

  • Open Access.

Decreased clinical performance in TGA-ASO patients after RVOT interventions; a multicenter European collaboration.

Engele LJ; (...); Bouma BJ

Article. 10.1016/j.ijcard.2024.132027. 2024

  • Open Access.

Decreased clinical performance in TGA-ASO patients after RVOT re-interventions; multicenter European collaboration

Engele, L.; (...); Bouma, B. J.

Meeting Abstract. 2023


Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018

  • Open Access.

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021


Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

  • Open Access.

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019


Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

  • Open Access.

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

  • Open Access.

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019


Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019


Diagnostic power of echocardiographic speckle tracking of the tricuspid annular motion to assess right ventricular dysfunction

Alonso P; (...); Salvador A

Letter. 10.1016/j.ijcard.2013.12.157. 2014


Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1016/j.healun.2021.10.004. 2022

  • Open Access.

Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure

Tarazón E; (...); Portolés M

Letter. 10.1016/j.ijcard.2014.04.037. 2014


Does the age of the recipient influence the survival of the heart transplant?

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019


Does the calcineurin inhibitor have influence on cytomegalovirus infection in heart transplantation?

Rodríguez-Serrano M; (...); Salvador-Sanz A

Article. 10.1111/ctr.12282. 2014


Does the Calcineurin Inhibitor Have Influence on Cytomegalovirus Infection in Heart Transplantation?

Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.

Article. 10.1016/j.healun.2014.01.067. 2014


Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).

Jimenez-Blanco, Marta; (...); Segovia-Cubero, Javier

Article. 10.1016/j.healun.2024.11.009. 2024

  • Open Access.

Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study)

Bravo, M. Jimenez -Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023


Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant

Bravo, M. Jimenez-Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023


Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.

Pérez Huertas P; (...); Poveda Andrés JL

Article. 10.7399/fh.2015.39.4.8839. 2015

  • Open Access.

Drug Interaction Between Oral Cyclosporine Modified and Iron

Domingo-Chiva, E; (...); Poveda-Andres, JL

Article. 10.1177/1060028013514734. 2014


Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Megias-Vericat, JE; (...); Poveda, JL

Review. 10.1007/s10072-017-2833-9. 2017


ECG determinants as markers of right ventricular dysfunction in patients with chronic right ventricular volume overload by congenital heart disease

Alonso Fernandez, P.; (...); Salvador, A.

Article. 2014


ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA

Sole A; (...); Casado MA

Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014

  • Open Access.

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018


Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

  • Open Access.

EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

Rojas, L.; (...); Alino, S. F.

Article. 2013


Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies

Rojas L; (...); Aliño SF

Article. 10.1038/tpj.2014.38. 2015


Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021


Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study.

Sánchez-González JL; (...); Marques-Sule E

Article. 10.3390/jcm12227090. 2023

  • Open Access.

EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY

Rojas, L.; (...); Alino, S. F.

Article. 2013


Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.

Gonzalez-Vilchez, F; (...); de Prada, JAV

Article. 10.1016/j.rec.2017.03.014. 2018


Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?

Playan Escribano, J.; (...); Del Cerro Marin, M. J.

Meeting Abstract. 2021


eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018


EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL?

Lopez-Vilella, R; (...); Almenar-Bonet, L

Meeting Abstract. 2021


Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis

Article. 10.3389/ti.2022.10197. 2022

  • Open Access.

Epidemiology of supplemental oxygen in patients with pulmonary hypertension.

Torres-Castro, Rodrigo; (...); Blanco, Isabel

Article. 10.1111/resp.14821. 2024

  • Open Access.

Essential ECG clues in patients with congenital heart disease and arrhythmias

Cano, O; (...); Martinez-Dolz, L

Article. 10.1016/j.jelectrocard.2016.08.005. 2017


ESTIMATION OF THE ECONOMIC AND SOCIAL BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN SPAIN

Zozaya, N.; (...); Hidalgo Vega, A.

Meeting Abstract. 2022


Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.

Marrero-Álvarez P; (...); Poveda-Andrés JL

Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014

  • Open Access.

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019


Evaluation of a near-zero fluoroscopic approach for catheter ablation in patients with congenital heart disease

Cano, O; (...); Mart?nez-Dolz, L

Article. 10.1007/s10840-018-0467-3. 2019


Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.006. 2022


Evolving Indications for Heart-Lung Transplant in Spain.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.003. 2022


Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 10.1016/j.gastrohep.2014.05.004. 2014


Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017


Experience with COVID-19 heart transplant patients in a tertiary hospital

Donoso, V.; (...); Almenar Bonet, L.

Article. 2021


Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

Esteban-Fernandez, Alberto; (...); Lopez-Vilella, Raquel

Article. 10.1002/ehf2.13976. 2022

  • Open Access.

EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY

Paz S; (...); Urcelay J

Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015

  • Open Access.

Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018


EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019


Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.

Klompstra L; (...); Marques-Sule E

Article. 10.1093/eurjcn/zvae144. 2024

  • Open Access.

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019


Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021


Fontan Circulation in Adult Patients: Acoustic Radiation Force Impulse Elastography as a Useful Tool for Liver Assessment.

Melero-Ferrer JL; (...); Rueda-Soriano J

Article. 10.1177/2150135114530172. 2014


Fontan procedure: imaging of normal post-surgical anatomy and the spectrum of cardiac and extracardiac complications

Navarro-Aguilar V; (...); Leiva-Salinas C

Review. 10.1016/j.crad.2014.10.005. 2015


Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry.

García-Cosío MD; (...); Delgado-Jiménez JF

Article. 10.1111/ctr.14096. 2020


Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy

Herrer I; (...); Rivera M

Article. 10.1186/s12920-015-0088-y. 2015


Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

  • Open Access.

Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

Bosó V; (...); Aliño SF

Article. 10.1097/FTD.0b013e3182a94e65. 2014


Golgi ribbon integrity in human patients with chronic heart failure

Gimenez Escamilla, I.; (...); Tarazon, E.

Meeting Abstract. 2021


Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022


Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017


Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018

  • Open Access.

Hazardous drugs: new challenges, new opportunities.

Valero García S; (...); Poveda Andrés JL

Article. 10.7399/fh.2016.40.2.10462. 2016

  • Open Access.

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

  • Open Access.

Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies

Artola, MJMJO; (...); Esteban, A

Meeting Abstract. 2018


Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital

Donoso, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2021


Heart transplantation and metabolic syndrome: which calcineurin inhibitor most promotes its development?

Martinez-Dolz, L.; (...); Salvador-Sanz, A.

Article. 2013


High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

  • Open Access.

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022


Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

  • Open Access.

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

  • Open Access.

How much does right ventricular dysfunction influence the elevation of NT-proBNP in patients with acute heart failure?

Vilella, RRL; (...); Bonet, LA

Meeting Abstract. 2018


Hyperkalemia in heart failure patients: current challenges and future prospects

Lopez-Vilella, R; (...); Almenar-Bonet, L

Review. 10.2147/RRCC.S75680. 2016

  • Open Access.

Hypertonic saline solution with furosemide for the treatment of congestive symptoms of acute heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018


Idarucizumab in High-risk Thoracic Surgery

Lopez-Vilella, R; (...); Almenar-Bonet, L

Article. 2018

  • Open Access.

Identification and validation of plasma micrornas involved in venous and arterial thrombosis

Ramon, L. A.; (...); Navarro, S.

Meeting Abstract. 2015


IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN ARTERIAL THROMBOSIS

Navarro, S.; (...); Espana, F.

Meeting Abstract. 10.1016/S0049-3848(14)50273-3. 2014


Identification of sarcomere serum biomarkers for non-invasive diagnosis of cardiac rejection

Perez Carrillo, L.; (...); Esther Rosello-Lleti, E.

Meeting Abstract. 2021


Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017


Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017

  • Open Access.

IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

  • Open Access.

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017

  • Open Access.

Impact of basal heart rate on long-term prognosis of heart transplant patients.

Melero-Ferrer JL; (...); Salvador-Sanz A

Article. 10.1111/tri.12082. 2013


Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

Martinez-Lauwers, Ana; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.08.041. 2021


Impact of circulatory assistance in the early evolution after heart transplantation: unicentric experience.

Martinez-Lauwers, A.; (...); Martinez-Dolz, L.

Meeting Abstract. 2020


Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020


Impact of comorbidities in outpatients with chronic heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018


Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis

Article. 10.1016/j.recesp.2020.02.018. 2020


Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.1002/ehf2.13753. 2022

  • Open Access.

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018


Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017


Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation

Ruiz J; (...); Aliño SF

Article. 10.3390/ijms160920168. 2015

  • Open Access.

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

  • Open Access.

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Meeting Abstract. 2015


Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019


Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.

Donoso-Trenado, Victor; (...); Almenar-bonet, Luis

Article. 10.1016/j.transproceed.2024.12.005. 2024


Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020


Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018


Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.

Perez-Carrillo, Lorena; (...); Tarazon, Estefania

Article. 10.3390/biomedicines10010135. 2022

  • Open Access.

Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021


Implications of Molecular Markers in Brain-Dead Donors in Primary Graft Dysfunction and Rejection After Heart Transplantation: The Potential Role of Preconditioning

Herrador-Galindo, L.; (...); Moreno-Gonzalez, G.

Meeting Abstract. 10.1016/j.healun.2024.02.526. 2024

  • Open Access.

Incidence and factors related to vasoplegia in the early postoperatory period of orthotopic heart transplantation

Vilella, RRL; (...); Bonet, LA

Meeting Abstract. 2018


Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor

López-Vilella R; (...); Montero-Argudo A

Article. 10.1016/j.transproceed.2014.11.025. 2015


Incidence of Development of Obesity After Heart Transplantation According to the Calcineurin Inhibitor (vol 47, pg 127, 2015)

Lopez-Vilella, R.; (...); Montero-Argudo, A.

Article. 10.1016/j.transproceed.2015.09.023. 2015


Incompatibility of undiluted busulfan injection with a needle-free valve

Cueto-Sola, M; (...); Poveda-Andres, JL

Letter. 10.2146/ajhp140111. 2014


Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285.

Bosó V; (...); Aliño SF

Article. 10.1124/dmd.112.047977. 2013


Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018


Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016


Infective endocarditis in patients with heart transplantation.

Martínez-Sellés M; (...); Muñoz P

Article. 10.1016/j.ijcard.2020.12.018. 2021


Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

Megías-Vericat JE; (...); Aliño SF

Review. 10.1038/tpj.2014.80. 2015


Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

  • Open Access.

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017


Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

García-Cosío MD; (...); Delgado JF

Article. 10.3389/fcvm.2021.630113. 2021

  • Open Access.

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018


Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021


Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Meeting Abstract. 2015


Influence of the type of circulatory/ventricular assistance in the primary graft failure and heart transplantation mortality

Vilella, RRL; (...); Bonet, LA

Meeting Abstract. 2018


Influence on kinesiophobia by disability, physical, and behavioural variables after a heart transplantation.

Marques-Sule E; (...); Bäck M

Article. 10.1093/eurjcn/zvab134. 2022


Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.

Bermejo San José F; (...); Sanromán-Álvarez L

Article. 10.7399/fh.2016.40.5.10180. 2016

  • Open Access.

Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center

Martin, PA; (...); Bonet, LA

Meeting Abstract. 2018


Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

  • Open Access.

Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant.

Bonet LA; (...); Sanz AS

Article. 10.5301/HEART.2014.12492. 2014


Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020


Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

  • Open Access.

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

  • Open Access.

Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?

Lopez-Vilella, Raquel; (...); Almenar Bonet L

Article. 10.3390/life13040915. 2023

  • Open Access.

Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?

Lopez Vilella, R. Raquel; (...); Bonet, L. Almenar

Meeting Abstract. 2023


Is there a variation of CA-125 levels with changes in glomerular filtration rate in patients with heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018


Is there changes in the diuretic response to hypertonic saline plus furosemide depending on the type of heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018


Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

  • Open Access.

Kinesiophobia and associated variables in patients with heart failure.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1093/eurjcn/zvad072. 2023

  • Open Access.

Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences

Moreno Segura, N.; (...); Marques-Sule, E.

Meeting Abstract. 2023


Kinesiophobia, physical activity and quality of life in patients with heart failure: a cross-sectional study

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022


Lack of agreement between the exercise variables to assess the risk in PAH

Martinez Menaca, Amaya; (...); Escribano Subias, Pliar

Meeting Abstract. 10.1183/13993003.congress-2021.OA142. 2021


Left atrial strain in adults after the arterial switch operation for transposition of the great arteries.

Buendia-Fuentes, Francisco; (...); Rueda, Joaquin

Article. 10.1111/echo.15750. 2024

  • Open Access.

Left ventricular systolic performance in adults after arterial switch operation. Echocardiographic data from EPOCH-ASO: a multi-centric international registry

Fernandez, V. Gonzalez; (...); Dos, L.

Meeting Abstract. 2023


Lesion-specific risk for sudden cardiac death or life-threatening ventricular arrhythmias in adult congenital heart disease

Gallego Garcia De Vinuesa, P.; (...); Oliver, J. M.

Meeting Abstract. 2019


Long term outcome of single ventricle physiology with pulmonary restriction not undergoing Fontan repair

Buendia, F; (...); Dos, L

Meeting Abstract. 2020


Long-term changes in left ventricular ejection fraction depending on the type of heart failure

Vilella, RRL; (...); Bonet, LA

Meeting Abstract. 2018


Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

  • Open Access.

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

  • Open Access.

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

  • Open Access.

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE; (...); Aliño SF

Article. 10.1097/FPC.0b013e3283642fb3. 2013


Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

  • Open Access.

Metabolic syndrome in heart transplantation: impact on survival and renal function.

Martínez-Dolz L; (...); Montero JA

Article. 10.1111/tri.12149. 2013


Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020


Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.

Ezzitouny, M.; (...); Martinez-Dolz, L.

Article. 10.1016/j.transproceed.2018.12.013. 2019


Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

  • Open Access.

Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018

  • Open Access.

Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2023


Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.1016/j.amjcard.2023.03.008. 2023

  • Open Access.

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

  • Open Access.

Musculoskeletal disorders in men and women with heart transplantation. A cross-sectional study

Segura, N. Moreno; (...); Marques-Sule, E.

Meeting Abstract. 2023


Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.

Vicente D; (...); D'Ocon P

Article. 10.1016/j.lfs.2013.05.025. 2013


N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM

Climente Martí M, Poveda Andrés JL, Culebras J

Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015

  • Open Access.

National consensus on the cardiological treatment and follow-up of Kawasaki disease

Sombrero, HR; (...); SECPCC

Article. 10.1016/j.anpedi.2018.04.003. 2018

  • Open Access.

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

  • Open Access.

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

  • Open Access.

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

  • Open Access.

Non-invasive diagnosis of cardiac rejection using small non-coding RNAs

Gimenez-Escamilla, I.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022


Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.

Núñez J; (...); Bayés-Genís A

Article. 10.1161/JAHA.119.014254. 2020

  • Open Access.

Noninvasive Liver Assessment in Adult Patients With Fontan Circulation Using Acoustic Radiation Force Impulse Elastography and Hepatic Magnetic Resonance Imaging.

Buendia-Fuentes, F; (...); Martinez-Dolz, L

Article. 10.1177/2150135117732674. 2018


Novel Imaging Techniques for Heart Failure.

Melero-Ferrer JL; (...); Martinez-Dolz L

Article. 10.15420/cfr.2015:29:2. 2016


Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

  • Open Access.

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

  • Open Access.

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

  • Open Access.

Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018


OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024


Paclitaxel and carboplatin treatment for advanced ovarian cancer during pregnancy.

Ruiz Ramos J; (...); Poveda JL

Article. 10.1159/000360691. 2013


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

  • Open Access.

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

  • Open Access.

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

  • Open Access.

Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Letter. 10.1016/j.recesp.2022.04.017. 2023


Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

  • Open Access.

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018


Pharmacogenomics and the treatment of acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Review. 10.2217/pgs-2016-0055. 2016


Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

  • Open Access.

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022


Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017

  • Open Access.

Phenotypic patterns of right ventricular dysfunction: analysis by cardiac magnetic imaging.

J Sánchez-Lázaro I; (...); Salvador-Sanz A

Article. 10.4081/hi.2013.e3. 2013


Physical activity enjoyment, exercise motivation, and physical activity in patients with heart failure: A mediation analysis.

Klompstra L; (...); Marques-Sule E

Article. 10.1177/02692155221103696. 2022

  • Open Access.

Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017


Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018


PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020


Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Lozano-Edo S; (...); Martínez-Dolz L

Article. 10.1097/TP.0000000000003798. 2021


Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

Megías-Vericat JE; (...); Aliño SF

Letter. 10.1038/tpj.2015.79. 2016


Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.

Romero S; (...); Sanz J

Article. 10.1080/10428194.2018.1474462. 2019


Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

  • Open Access.

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018


Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.

Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C

Article. 10.1111/ctr.70027. 2025


Predicting sudden cardiac death in adults with congenital heart disease.

Oliver JM; (...); Spanish ACHD Network

Article. 10.1136/heartjnl-2020-316791. 2021


PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

  • Open Access.

Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2021


Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

  • Open Access.

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

  • Open Access.

Presence and evolution of multiple pulmonary nodules with halo sign detected by computerized tomography in advanced heart failure

Vilella, RRL; (...); Bonet, LA

Meeting Abstract. 2018


Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

  • Open Access.

Prevalence of fragmented QRS complex and factors related with its occurrence

Martinez-Dolz, L.; (...); Almenar-Bonet, L.

Article. 2014


Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.

Lopez-Vilella, Raquel; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.09.009. 2022

  • Open Access.

Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction

Otero Garcia, O.; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 2024


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

  • Open Access.

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry

Vega, D. Garcia; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.1187. 2024

  • Open Access.

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry

Garcia Vega, D. David; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.1187. 2024

  • Open Access.

Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Article. 2014


Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Article. 2014


PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS

Megias Vericat, J. E.; (...); Sanz, M. A.

Article. 2015

  • Open Access.

Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.

Laymito-Quispe RDP; (...); Almenar-Bonet, Luis

Article. 10.1016/j.medcli.2021.03.037. 2022


Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1097/DSS.0000000000001046. 2017


Pulmonary arterial hypertension associated with pretricuspid shunts: risk profile and survival.

Calvo-Asensio, Maria; (...); Rueda Soriano, Joaquin

Article. 10.1016/j.rec.2024.04.016. 2024

  • Open Access.

Pulmonary hypertension and congenital heart disease: medical treatment and risk factors for survival

Escribano, JP; (...); Subias, PE

Meeting Abstract. 2020


Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018


Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.

Cuéllar Monreal MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.2017.41.1.10434. 2017

  • Open Access.

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.

Ufnal, Marcin; (...); Rosenkranz, Stephan

Article. 10.1002/ehf2.15203. 2025

  • Open Access.

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

De Juan Baguda, J. Javier; (...); Gonzalez-Costello, J.

Meeting Abstract. 2022


Repetitive ambulatory levosimendan as a bridge to heart transplantation.

Baguda, Javier De Juan; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2023.07.002. 2023

  • Open Access.

Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation

Vilella, RL; (...); Bonet, LA

Meeting Abstract. 2018


Role of DNMT3B system in human ischemic hearts

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021


Safety and feasibility of conduction system pacing in patients with congenital heart disease

Cano, O; (...); Vijayaraman, P

Article. 10.1111/jce.15213. 2021

  • Open Access.

Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018

  • Open Access.

Sarcomere ACTC1 and MYO18A serum expression levels detect acute cellular rejection in cardiac transplant patients

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021


SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020

  • Open Access.

Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/1078155212457964. 2013


Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris M; (...); Nos, P

Article. 10.1097/MIB.0000000000001182. 2017

  • Open Access.

Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Aguas, M; (...); Nos, P

Meeting Abstract. 2017


Severity of Donor Transmitted Coronary Artery Disease and Survival after Heart Transplantation. Results from the Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023


Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.

Del Canto I; (...); Núñez J

Article. 10.1161/JAHA.121.022214. 2022

  • Open Access.

Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation

Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.

Article. 10.1016/j.healun.2014.01.392. 2014


Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Otero Garcia, O. Oscar; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.836. 2024

  • Open Access.

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.836. 2024

  • Open Access.

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

  • Open Access.

SNPs and taxane toxicity in breast cancer patients

Bosó V; (...); Aliño SF

Article. 10.2217/PGS.14.127. 2014


Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.ejim.2022.06.008. 2022


Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

Cantón R; (...); Solé A

Article. 10.1016/j.arbres.2014.09.021. 2015


Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure

Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T

Article. 10.1016/j.recesp.2018.07.020. 2018


Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)

Gonzalez-Vilchez, F; (...); Abella-Anton, R

Article. 10.1016/j.rec.2019.09.005. 2019


Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vilchez F; (...); Groba Marco MDV

Article. 10.1016/j.rec.2020.06.035. 2020


Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)

Sinning, Christoph; (...); Kirchhof, Paulus

Article. 10.1002/ehf2.13574. 2021

  • Open Access.

Study of molecules involved in cellular traffic in advanced heart failure: are there differences in the nivels of these molecules between ischemic heart disease and idiopathic dilated cardiomyopathy?

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018


Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital

Pérez-Cebrián M; (...); Llopis-González A

Article. 2015


Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022

  • Open Access.

Technology Usage, Physical Activity, and Motivation in Patients With Heart Failure and Heart Transplantation.

Deka P; (...); Marques-Sule E

Article. 10.1097/CIN.0000000000001049. 2023


The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022


The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022

  • Open Access.

The coronavirus disease pandemic among adult congenital heart disease patients and the lessons learnt - results of a prospective multicenter european registry.

Ruperti-Repilado, Francisco Javier; (...); Schwerzmann, Markus

Article. 10.1016/j.ijcchd.2022.100428. 2023

  • Open Access.

The economic burden of pulmonary arterial hypertension in Spain.

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.1186/s12890-022-01906-2. 2022

  • Open Access.

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.

López-Vilella R; (...); Almenar Bonet L

Article. 10.3389/fcvm.2021.618398. 2021

  • Open Access.

The Role of Conventional and Right-Sided ECG Screening for Subcutaneous ICD in a Tetralogy of Fallot Population

Alonso, P; (...); Sancho-Tello, MJ

Article. 10.1111/pace.13017. 2017


The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

  • Open Access.

The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus

Torrent-Farnell, J; (...); Lizan, L

Article. 10.1016/j.healthpol.2018.03.002. 2018


Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2023


Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

López-Vilella R; (...); Almenar Bonet L

Article. 10.1002/ehf2.14386. 2023

  • Open Access.

Three cases of psychosis after use of sacubitril/valsartan.

Perez-Rosello, Victor; (...); Almenar-Bonet, Luis

Letter. 10.1016/j.recesp.2020.05.019. 2021


Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation.

Rueda Soriano, Joaquin; (...); Gallego, Pastora

Article. 10.1016/j.recesp.2020.01.031. 2020


Tolvaptan in hyponatremic patients with heart failure: initial experience

Martinez-Dolz, L.; (...); Salvador-Sanz, A.

Article. 2013


Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020


Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020

  • Open Access.

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.

Megías Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.rx.2015.01.008. 2015


Transient pulmonary nodules with halo sign in patients with advanced heart failure: a report of two cases.

López-Vilella R; (...); Bonet LA

Article. 10.1016/j.clinimag.2019.11.008. 2020


Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature

Lizan, L; (...); Polanco, C

Review. 10.2147/PPA.S67253. 2014

  • Open Access.

Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022

  • Open Access.

Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020


Univentricular hearts not undergoing Fontan: the type of palliation matters.

Gordon, Blanca; (...); Subira, Laura Dos

Article. 10.1016/j.rec.2023.03.001. 2024

  • Open Access.

Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.835. 2024

  • Open Access.

Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018


Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients

García-Robles AA; (...); Poveda JL

Letter. 10.1016/j.jns.2016.04.048. 2016


Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.

Alonso P; (...); Montero A

Article. 2014


USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

  • Open Access.

Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain

Crespo-Leiro, MGMG; (...); Almenar-Bonet, L

Meeting Abstract. 2019


Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.

Crespo-Leiro MG; (...); Almenar-Bonet L

Article. 10.1111/ctr.13748. 2019


Use of tolvaptan in patients with hyponatremia due to heart failure: initial experience.

Rodríguez-de Muñoz YM; (...); Salvador-Sanz A

Letter. 10.1016/j.rec.2012.09.010. 2013


Usefulness of biomarkers to predict prognosis after heart transplant

Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar

Article. 10.1016/j.rec.2024.04.019. 2024

  • Open Access.

Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary Experience.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.transproceed.2021.07.051. 2021


Usefulness of short-term peripheral ambulatory ultrafiltration in heart failure refractory to diuretics. Initial experience.

Guerrero Cervera B; (...); Almenar Bonet L

Article. 10.1016/j.medcli.2023.04.008. 2023


Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019


Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant

Ezzitouny, M.; (...); Marinez-Dolz, L.

Meeting Abstract. 2020


Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.07.058. 2021


Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study.

Goirigolzarri Artaza, Josebe; (...); Segovia Cubero, Javier

Article. 10.1016/j.recesp.2020.01.033. 2020


VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023


Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Ezzitouny M; (...); Martínez-Dolz L

Article. 10.3390/jpm11111122. 2021

  • Open Access.

Value of the Electrocardiogram as a Predictor of Right Ventricular Dysfunction in Patients With Chronic Right Ventricular Volume Overload.

Alonso P; (...); Salvador A

Article. 10.1016/j.rec.2014.04.019. 2015


Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Variations in the medical treatment of heart failure during admission for decompensation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022


Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study

Marques-Sule, Elena; (...); Luis Cabanillas-Garcia, Juan

Article. 10.3390/ijerph192215316. 2022

  • Open Access.

What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Bonet, Almenar

Meeting Abstract. 2024


What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Donoso Trenado, V.; (...); Almenar-Bonet, L.

Meeting Abstract. 2024


What motivates heart transplantation patients to exercise and engage in physical activity? A network analysis.

Marques-Sule, Elena; (...); Machado, Felipe V C

Article. 10.1093/eurjcn/zvad051. 2023


Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.3390/life12111828. 2022

  • Open Access.

Campos de estudio

Compartir